Complications of BCG immunotherapy in patients with cancer.
D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D005334:Fever / Q000209:etiology; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D007267:Injections; D007271:Injections, Intradermal; D007538:Isoniazid / Q000627:therapeutic use; D007565:Jaundice / Q000209:etiology; D008107:Liver Diseases / Q000209:etiology; D008206:Lymphatic Diseases / Q000209:etiology; D008722:Methods; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D011537:Pruritus / Q000209:etiology; D013546:Sweating; D014456:Ulcer / Q000209:etiology; D014612:Vaccines / Q000008:administration & dosage
D001500:BCG Vaccine; D014612:Vaccines; D007538:Isoniazid